Dagenham, United Kingdom

Sukanthini Thurairatnam


Average Co-Inventor Count = 10.0

ph-index = 5

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sukanthini Thurairatnam

Introduction

Sukanthini Thurairatnam is a notable inventor based in Dagenham, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of five patents to his name, Thurairatnam has focused on developing compounds that have important therapeutic applications.

Latest Patents

Thurairatnam's latest patents include compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom-containing linking group. This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention also encompasses the preparation of these compounds and pharmaceutical compositions containing them. Furthermore, it addresses the pharmaceutical use of these compounds for inhibiting cyclic AMP phosphodiesterase.

Career Highlights

Throughout his career, Sukanthini Thurairatnam has worked with prominent companies in the pharmaceutical industry, including Rhone Poulenc Rorer and Aventis Pharma Limited. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Thurairatnam has collaborated with notable colleagues such as Garry Fenton and Andrew David Morley. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Sukanthini Thurairatnam's innovative work in pharmaceuticals, particularly through his patents, showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest for effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…